Topical Steroids and Cyclosporin-A for COVID-19 Keratoconjunctivitis

• Status: Not yet recruiting
• Trial end date: 2020-07-01
• Target enrollment: 0
• Participant gender: All

Summary

To explore the feasibility of combined topical corticosteroid and topical cyclosporine-A in COVID-19 patients with acute keratoconjunctivitis.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ameera Gamal Abdelhameed
• Collaborator: Ministry of Health, Kuwait
• Treatments: Cyclosporine; Cyclosporins

Criteria

Inclusion Criteria:

• COVID-19 Patients with keratoconjunctivitis

Exclusion Criteria:

• associated ocular pathology or disease

• other causes of keratoconjunctivitis for example allergic or herpetic